To main content

Effects of low doses of fish and milk proteins on glucose regulation and markers of insulin sensitivity in overweight adults: a randomised, double blind study

Effects of low doses of fish and milk proteins on glucose regulation and markers of insulin sensitivity in overweight adults: a randomised, double blind study

Category
Journal publication
Abstract
Purpose To examine whether supplementation with low doses of fish or milk proteins would affect glucose regulation and circulating lipid concentrations in overweight healthy adults. Methods Ninety-three overweight adults were assigned to receive 2.5 g protein/day from herring (HER), salmon (SAL), cod (COD) or milk (CAS, a casein–whey mixture as positive control) as tablets for 8 weeks. Results Seventy-seven participants were included in the analyses. HER and SAL did not affect glucose and insulin concentrations. COD significantly reduced within-group changes in 90 and 120 min postprandial glucose concentrations but changes were not different from HER and SAL groups. CAS supplementation significantly reduced the area under the curve for glucose concentrations (− 7%), especially when compared to SAL group, and reduced postprandial insulin c-peptide concentration (− 23%). Reductions in acetoacetate (− 24%) and β-hydroxybutyrate (− 29%) serum concentrations in HER group were more prominent compared to SAL and COD groups, with no differences between fish protein groups for α-hydroxybutyrate. Serum concentrations of α-hydroxybutyrate (− 23%), acetoacetate (− 39%) and β-hydroxybutyrate (− 40%) were significantly reduced within CAS group, and the decreases were significantly more pronounced when compared to SAL group. Serum lipid concentrations were not altered in any of the intervention groups. Conclusion Findings indicate that 2.5 g/day of proteins from fish or milk may be sufficient to improve glucose regulation in overweight adults. The effects were most pronounced after supplementation with proteins from cod, herring and milk, whereas salmon protein did not affect any of the measurements related to glucose regulation. Clinical trail registration This trial was registered at clinicaltrials.gov as NCT01641055.
Client
  • Regionale forskningsfond Vestlandet / 212625
Language
English
Author(s)
  • Hovland Ida Heir
  • Leikanger Ingrid Sande
  • Stokkeland Oddbjørg
  • Waage Kaia Hevrøy
  • Mjøs Svein Are
  • Brokstad Karl Albert
  • McCann Adrian
  • Ueland Per Magne
  • Slizyte Rasa
  • Carvajal Ana Karina
  • Mellgren Gunnar
  • Remman Tore
  • Høgøy Ingmar Johan
  • Gudbrandsen Oddrun Anita
Affiliation
  • University of Bergen
  • University of Bergen
  • University of Bergen
  • Nofima, The Norwegian Institute of Food, Fisheries and Aquaculture Research
  • University of Bergen
  • Bevital
  • Bergen Hospital Trust - Haukeland University Hospital
  • SINTEF Ocean / Sjømatteknologi
  • Bergen Hospital Trust - Haukeland University Hospital
  • Nutrimar Holding AS
  • Diverse norske bedrifter og organisasjoner
  • Bergen Hospital Trust - Haukeland University Hospital
Year
2019
Published in
European Journal of Nutrition
ISSN
1436-6207
Publisher
Steinkopff-Verlag
Page(s)
1 - 17